Pharmacogenomics in Tailoring First-Line Therapy for Breast Cancer: PharmGKB Database Insights
View ORCID ProfileMurilo Porfírio de Aguiar
doi: https://doi.org/10.1101/2023.11.28.23299155
Murilo Porfírio de Aguiar
1Federal Unniversity of Triangulo Mineiro, Brazil
Data Availability
All data produced in the present work are contained in the manuscript.
Posted December 01, 2023.
Pharmacogenomics in Tailoring First-Line Therapy for Breast Cancer: PharmGKB Database Insights
Murilo Porfírio de Aguiar
medRxiv 2023.11.28.23299155; doi: https://doi.org/10.1101/2023.11.28.23299155
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2960)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4604)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (472)
- Neurology (4383)
- Nursing (237)
- Nutrition (641)
- Oncology (2282)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6967)
- Radiology and Imaging (1537)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)